InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nuvation Bio Inc.

NUVB Clue Score46
United States Fiscal year ends December CIK 0001811063 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

71
Insider
Date
Role
Action
Shares
Price
Amount
Gary Hattersley
19 Aug 2026
Chief Scientific Officer
Sold after exercise
100,000
$7.09
$709.24K
Philippe Sauvage
15 Jul 2026
Chief Financial Officer
Exercised, kept
1
$1.97
$1.97
Philippe Sauvage
15 Jul 2026
Chief Financial Officer
Exercised, kept
39,999
$2.17
$86.80K
Philippe Sauvage
23 Jun 2026
Chief Financial Officer
Sold after exercise
47,668
$6.01
$286.37K
Kerry Wentworth
23 Jun 2026
Chief Regulatory Officer
Sold after exercise
63,000
$6.02
$379.19K
Stacy Markel
23 Jun 2026
Chief People Officer
Sold after exercise
125,000
$6.03
$753.19K
Robert Mashal
9 Jun 2026
Director
Buy indirect
25,000
$4.73
$118.25K
Dongfang Liu
17 Apr 2026
Chief Medical Officer
Sold after exercise
50,000
$5.02
$251.00K
Kerry Wentworth
17 Apr 2026
Chief Regulatory Officer
Sold after exercise
36,750
$5.01
$184.28K
Kerry Wentworth
6 Apr 2026
Chief Regulatory Officer
Sold after exercise
200,000
$4.52
$903.56K
Dongfang Liu
1 Dec 2025
Chief Medical Officer
Sold after exercise
150,000
$7.82
$1.17M
Dongfang Liu
26 Nov 2025
Chief Medical Officer
Sold after exercise
10,000
$8.00
$80.00K
Dongfang Liu
25 Nov 2025
Chief Medical Officer
Sold after exercise
10,000
$7.50
$75.00K
Dongfang Liu
20 Nov 2025
Chief Medical Officer
Sold after exercise
20,000
$7.00
$140.07K
Gary Hattersley
20 Nov 2025
Chief Scientific Officer
Sold after exercise
300,000
$7.23
$2.17M
Gary Hattersley
20 Nov 2025
Chief Scientific Officer
Sold after exercise
69,051
$7.23
$499.03K
Dongfang Liu
19 Nov 2025
Chief Medical Officer
Sold after exercise
15,000
$5.10
$76.55K
David C. Hanley
19 Nov 2025
Chief Technical Operations
Sold after exercise
200,000
$7.14
$1.43M
Dongfang Liu
17 Nov 2025
Chief Medical Officer
Sold after exercise
15,000
$4.77
$71.48K
Gary Hattersley
27 Oct 2025
Chief Scientific Officer
Sold after exercise
100,000
$5.02
$502.46K
Stacy Markel
18 Jun 2025
Chief People Officer
Buy
10,000
$1.71
$17.10K
Philippe Sauvage
17 Jun 2025
Chief Financial Officer
Buy
4,000
$1.79
$7.16K
David Hung
16 Jun 2025
President and CEO
Buy
500,000
$1.79
$893.50K
Kerry Wentworth
16 Jun 2025
Chief Regulatory Officer
Buy
24,000
$1.80
$43.20K
Kerry Wentworth
16 Jun 2025
Chief Regulatory Officer
Buy
26,000
$1.79
$46.54K
Colleen Sjogren
16 Jun 2025
Chief Commercial Officer
Buy
50,000
$1.81
$90.35K
Philippe Sauvage
16 Jun 2025
Chief Financial Officer
Buy
3,300
$1.84
$6.06K
Dongfang Liu
2 May 2025
Chief Medical Officer
Sold after exercise
20,000
$2.50
$50.02K
David Hung
7 Apr 2025
President and CEO
Buy
300,000
$1.63
$487.50K
David Hung
4 Apr 2025
President and CEO
Buy
200,000
$1.66
$332.72K
Robert Mashal
1 Apr 2025
Director
Buy indirect
98,900
$1.67
$165.15K
Robert Mashal
1 Apr 2025
Director
Buy indirect
1,100
$1.67
$1.83K
Junyuan Jerry Wang
11 Nov 2024
CEO, Anheart Therapeutics Ltd.
Sell
56,361
$2.89
$162.88K
Robert Mashal
8 Oct 2024
Director
Buy indirect
99,981
$2.20
$219.96K
Robert Mashal
8 Oct 2024
Director
Buy indirect
19
$2.20
$41.71
Xiangmin Cui
25 Jun 2024
Director
Buy indirect
277,895
$2.97
$825.35K
Xiangmin Cui
24 Jun 2024
Director
Buy indirect
336,874
$2.98
$1.00M
Xiangmin Cui
21 Jun 2024
Director
Buy indirect
75,411
$3.00
$226.23K
Xiangmin Cui
20 Jun 2024
Director
Buy indirect
87,715
$2.99
$262.27K
Kim D Blickenstaff
11 Jun 2024
Director
Buy indirect
172,189
$2.90
$500.09K
Daniel G Welch
24 May 2024
Director
Exercised, kept
366,744
$1.64
$601.46K
Daniel G Welch
24 May 2024
Director
Exercised, kept
293,203
$1.74
$510.17K
Oleg Nodelman
21 Feb 2023
Director
Buy indirect
53,000
$1.36
$72.14K
Oleg Nodelman
20 Feb 2023
Director
Buy indirect
117,100
$1.36
$159.49K
Oleg Nodelman
19 Feb 2023
Director
Buy indirect
5,143,000
$1.26
$6.46M
Kathryn E Falberg
5 Dec 2022
Director
Buy indirect
43,000
$1.95
$83.96K
Kathryn E Falberg
2 Dec 2022
Director
Buy indirect
47,000
$1.98
$93.19K
Kathryn E Falberg
1 Dec 2022
Director
Buy indirect
84,959
$1.97
$167.60K
Kathryn E Falberg
30 Nov 2022
Director
Buy indirect
75,041
$1.85
$139.09K
Omega Fund V, L.P.
5 Apr 2022
10% owner
Sell
2,500,000
$5.60
$14.00M
Omega Fund V, L.P.
15 Dec 2021
10% owner
Sell
500,000
$10.07
$5.04M
Omega Fund V, L.P.
7 Dec 2021
10% owner
Sell
1,400,000
$9.80
$13.72M
Oleg Nodelman
24 Nov 2021
Director
Buy indirect
21,758
$7.69
$167.23K
Oleg Nodelman
24 Nov 2021
Director
Buy indirect
163,268
$7.69
$1.25M
Omega Fund V, L.P.
23 Nov 2021
10% owner
Sell
36
$9.75
$351.00
Omega Fund V, L.P.
22 Nov 2021
10% owner
Sell
295,000
$9.76
$2.88M
Omega Fund V, L.P.
3 Nov 2021
10% owner
Sell
2,000,000
$9.25
$18.50M
Omega Fund V, L.P.
29 Oct 2021
10% owner
Sell
45,000
$9.27
$417.15K
Omega Fund V, L.P.
28 Oct 2021
10% owner
Sell
1,015,000
$9.60
$9.74M
Oleg Nodelman
31 Jul 2021
Director
Sell indirect
56,598
$8.64
$489.01K
Oleg Nodelman
31 Jul 2021
Director
Buy indirect
56,598
$8.64
$489.01K
Oleg Nodelman
13 Apr 2021
Director
Buy indirect
3,966
$10.27
$40.73K
Oleg Nodelman
13 Apr 2021
Director
Buy indirect
27,534
$10.27
$282.80K
Oleg Nodelman
12 Apr 2021
Director
Buy indirect
16,745
$9.49
$158.87K
Oleg Nodelman
12 Apr 2021
Director
Buy indirect
116,255
$9.49
$1.10M
Oleg Nodelman
9 Apr 2021
Director
Buy indirect
37,770
$10.03
$378.86K
Oleg Nodelman
9 Apr 2021
Director
Buy indirect
262,230
$10.03
$2.63M
Oleg Nodelman
31 Mar 2021
Director
Sell indirect
151,544
$10.45
$1.58M
Oleg Nodelman
31 Mar 2021
Director
Buy indirect
151,544
$10.45
$1.58M
Robert B Bazemore
30 Mar 2021
Director
Buy
5,000
$9.98
$49.90K
EcoR1 Panacea Holdings, LLC
6 Jul 2020
Director
Buy
390,000
$10.00
$3.90M

What was left out

Form 4 filings counted 146
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 18
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 114,572,402
Sales filed before the plan box existed 10
History held since 6 Jul 2020